Raymond James & Associates’s Envision Healthcare Holdings Inc EVHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-60,965
| Closed | -$2.79M | – | 3820 |
|
|
2018
Q3 | $2.79M | Sell |
60,965
-38,593
| -39% | -$1.73M | ﹤0.01% | 1602 |
|
|
2018
Q2 | $4.38M | Sell |
99,558
-48,513
| -33% | -$1.99M | 0.01% | 1274 |
|
|
2018
Q1 | $5.69M | Buy |
148,071
+41,986
| +40% | +$1.57M | 0.01% | 1077 |
|
|
2017
Q4 | $3.67M | Sell |
106,085
-215,652
| -67% | -$7.54M | 0.01% | 1303 |
|
|
2017
Q3 | $14.5M | Sell |
321,737
-7,453
| -2% | -$397K | 0.03% | 568 |
|
|
2017
Q2 | $20.6M | Sell |
329,190
-12,369
| -4% | -$713K | 0.04% | 423 |
|
|
2017
Q1 | $20.9M | Sell |
341,559
-55,519
| -14% | -$3.72M | 0.05% | 380 |
|
|
2016
Q4 | $25.1M | Buy |
397,078
+371,408
| +1,447% | +$24.3M | 0.06% | 298 |
|
|
2016
Q3 | $1.71M | Sell |
25,670
-673
| -3% | -$46.4K | ﹤0.01% | 1555 |
|
|
2016
Q2 | $2M | Buy |
26,343
+1,661
| +7% | +$118K | 0.01% | 1330 |
|
|
2016
Q1 | $1.51M | Buy |
24,682
+8,695
| +54% | +$571K | 0.01% | 1453 |
|
|
2015
Q4 | $1.24M | Sell |
15,987
-3,798
| -19% | -$328K | ﹤0.01% | 1515 |
|
|
2015
Q3 | $2.18M | Buy |
19,785
+71
| +0.4% | +$8.79K | 0.01% | 1167 |
|
|
2015
Q2 | $2.33M | Buy |
19,714
+10,496
| +114% | +$1.19M | 0.01% | 1230 |
|
|
2015
Q1 | $1.06M | Sell |
9,218
-880
| -9% | -$95.7K | ﹤0.01% | 1628 |
|
|
2014
Q4 | $1.05M | Sell |
10,098
-1,559
| -13% | -$160K | 0.01% | 1546 |
|
|
2014
Q3 | $1.21M | Buy |
11,657
+1,352
| +13% | +$143K | 0.01% | 1387 |
|
|
2014
Q2 | $1.11M | Buy |
+10,305
| New | +$1.06M | 0.01% | 1432 |
|
Other funds holding EVHC
Raymond James & Associates's EVHC Position: Q4 2018 in Review
Raymond James & Associates sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 60,965 shares — an estimated $2.79M sold.
Raymond James & Associates first reported a position in EVHC in Q2 2014 and held it in 18 quarters. The position peaked at $25.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.
- Raymond James & Associates reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
- Raymond James & Associates sold 60,965 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $2.79M.
- Raymond James & Associates first reported a position in Envision Healthcare Holdings Inc in Q2 2014 and held it in 18 quarters.
- Raymond James & Associates's Envision Healthcare Holdings Inc position peaked at $25.1M in Q4 2016.
- 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.
Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.